NCT06743880Not yet recruiting
Knowledge, Attitude &Practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
Knowledge,Attitude &Practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
Source: ClinicalTrials.gov · Last updated 20 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
* Cervical cancer is caused by persistent infection with certain strains of the human papillomavirus (HPV), which is a very common virus transmitted through sexual activity. * HPV infections can lead to the development of precancerous lesions on the cervix, which if left untreated, can progress to invasive cervical cancer over time. * Cervical cancer is the second most common cancer among women in Egypt, after breast cancer. * According to the latest available data, the age-standardized incidence rate of cervical cancer in Egypt is approximately 6.3 per 100,000 women. * However, the actual burden of cervical cancer in Egypt is likely underestimated, as many cases may go undetected or unreported, especially in rural and underserved areas. The main objectives of this KAP study are: 1. To assess the level of knowledge about HPV and HPV vaccination among the target population. 2. To investigate the attitudes and perceptions towards HPV vaccination. 3. To identify the current practices and uptake of HPV vaccination. 4. To explore the factors influencing the knowledge, attitudes, and practices related to HPV vaccination.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 323 (estimated)
- First submitted
- 17 Dec 2024
- Start date
- 1 Jan 2025
- Primary completion date
- 1 Jan 2025
- Lead sponsor
- Assiut University
- NCT number
- NCT06743880
What you commit to
- Study type: Observational
- Planned participants: 323
- From 1 Jan 2025 to the primary completion date, 1 Jan 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- -Previous HPV Vaccination:
- Exclude participants who have already received the complete HPV vaccination series, as their knowledge, attitudes, and practices may differ from those who are unvaccinated.
Other illness
- The study aims to understand the KAP of the unvaccinated population, which is the primary target group for intervention.
- 2-Severe Cognitive or Mental Impairment:
- This could include individuals with advanced dementia, severe intellectual disabilities, or acute psychiatric conditions.
- 3-. Inability to Provide Informed Consent:
- Exclude participants who are unable to provide informed consent due to language barriers, literacy issues, or other factors that may compromise their ability to understand the study and its implications 4- Severe Illness or Hospitalization:
- Exclude participants who are currently hospitalized or experiencing severe illness, as their focus may be on their immediate health concerns rather than the KAP questionnaire.
Other
- Exclude participants who have severe cognitive or mental impairments that may prevent them from understanding and responding to the questionnaire accurately.
Who the study is looking for
- 1\. general population:
- Eligibility criteria:
- Age: 9-79 years old
- patients and their relatives
- Attending the Obstetrics and Gynecology, or Family Medicine clinics at Assiut University Hospital
- Recruitment strategy:
- Using a systematic random sampling method, every nth patient (based on the average patient load) will be approached and invited to participate in the study.
- The target sample size for patients is a minimum of 384 participants.
- 2\. Healthcare providers:
- Eligibility criteria:
- Physicians, nurses, and other healthcare workers employed in the Obstetrics and Gynecology, and Family Medicine departments at Assiut University Hospital.
Age in the registry: 9 years to 79 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.